Patients are getting what purport to be these substances, or are using drugs that are made with research-grade active ingredients, and I almost expect any day now theres going to be some serious patient adverse event or a series of patients who are made ill or worse by taking batches of these drugs that were not made to FDA standards or with active ingredients that are not made to FDA standards, Brunner said
A common pattern involves using nasal spray for TB-500 systemic delivery while injecting BPC-157 locally at specific injury sites
FDA guidance for RUO-labeled in vitro diagnostic products explains that RUO labeling is meant to identify materials in a laboratory research phase and distinguish them from diagnostic contexts [16]
Current Neuropharmacology For laboratory and in-vitro research use only
BPC-157 + TB-500 BPC-157 (10mg) + TB-500 (10mg) paired repair peptides studied across complementary tissue healing pathways
[DOI] [PubMed] [Google Scholar] 76.Zivanovic-Posilovic G., Balenovic D., Barisic I., Strinic D., Stambolija V., Udovicic M., Uzun S., Drmic D., Vlainic J., Bencic M.L., et al